p38 MAP kinase's emerging role as a tumor suppressor

Advances in Cancer Research

Volumn 92, Issue , 2004, Pages 95-118

  Bulavin, Dmitry V ^a   Fornace Jr , Albert J ^b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P16; PROTEIN P19; PROTEIN P53; PROTEIN P73; PROTEIN TYROSINE PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER SCREENING; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; NONHUMAN; ONCOGENE; PREMATURE AGING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 7644223136     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(04)92005-2     Document Type: Article

References (111)

1. Adachi M., Nishida E. Subcellular localization of MAPKs. Methods Mol. Biol. 250:2004;145-154
2. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., Nebreda A.R. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell. 6:2000;109-116
3. Aguirre-Ghiso J.A., Estrada Y., Liu D., Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res. 63:2003;1684-1695
4. Alani R.M., Young A.Z., Shifflett C.B. Id1 regulation of cellular senescence through transcriptional repression of p16Ink4a. Proc. Natl. Acad. Sci. USA. 98:2001;7812-7816
5. Alt J.R., Cleveland J.L., Hannink M., Diehl J.A. Phosphorylation- dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:2000;3102-3114
6. Ambrosino C., Mace G., Galban S., Fritsch C., Vintersten K., Black E., Gorospe M., Nebreda A.R. Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase. Mol. Cell. Biol. 23:2003;370-381
7. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2001;2764-2772
8. Bartek J., Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 13:2001;738-747
9. Behr T.M., Berova M., Doe C.P., Ju H., Angermann C.E., Boehm J., Willette R.N. p38 mitogen-activated protein kinase inhibitors for the treatment of chronic cardiovascular disease. Curr. Opin. Investig. Drugs. 4:2003;1059-1064
10. Brancho D., Tanaka N., Jaeschke A., Ventura J.J., Kelkar N., Tanaka Y., Kyuuma M., Takeshita T., Flavell R.A., Davis R.J. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17:2003;1969-1978
11. Bulavin D.V., Amundson S.A., Fornace A.J. p38 and Chk1 kinases: Different conductors for the G(2)M checkpoint symphony. Curr. Opin. Genet. Dev. 12:2002a;92-97
12. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., Kallioniemi A., Fornace A.J.J., Appella E. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31:2002b;210-215
13. Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V., Potapova O., Appella E., Fornace A.J.J. Initiation of a G2M checkpoint after ultraviolet radiation requires p38 kinase. Nature. 411:2001;102-107
14. Bulavin D.V., Kovalsky O., Hollander M.C., Fornace A.J.J. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol. Cell. Biol. 23:2003;3859-3871
15. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., Fornace A.J. Jr. Inactivation of the wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the Ink4aArf pathway. Nat. Genet. 36:2004;343-350
16. Bulavin D.V., Saito S., Hollander M.C., Sakaguchi K., Anderson C.W., Appella E., Fornace A.J. Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18:1999;6845-6854
17. Campisi J. Replicative senescence: An old lives' tale? Cell. 84:1996;497-500
18. Cangi M.G., Cukor B., Soung P., Signoretti S., Moreira G.J., Ranashinge M., Cady B., Pagano M., Loda M. Role of the Cdc25A phosphatase in human breast cancer. J. Clin. Invest. 106:2000;753-761
19. Carnero A., Hudson J.D., Price C.M., Beach D.H. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2:2000;148-155
20. Casanovas O., Miro F., Estanyol J.M., Itarte E., Agell N., Bachs O. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275:2000;35091-35097
21. Chen M.S., Ryan C.E., Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol. Cell. Biol. 23:2003;7488-7497
22. Cheung P.C., Campbell D.G., Nebreda A.R., Cohen P. Feedback control of the protein kinase TAK1 by SAPK2ap38alpha. EMBO J. 22:2003;5793-5805
23. Choi J., Nannenga B., Demidov O.N., Bulavin D.V., Cooney A., Brayton C., Zhang Y., Mbawuike I.N., Bradley A., Appella E., Donehower L.A. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1)exhibit defects in reproductive organs, immune function, and cell cycle control. Mol. Cell. Biol. 22:2002;1094-1105
24. Crawley J.B., Rawlinson L., Lali F.V., Page T.H., Saklatvala J., Foxwell B.M. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J. Biol. Chem. 272:1997;15023-15027
25. D'Aversa T.G., Weidenheim K.M., Berman J.W. CD40-CD40L interactions induce chemokine expression by human microglia: Implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am. J. Pathol. 160:2002;559-567
26. Damodar Reddy C., Marwaha S., Patti R., Raghunath M., Duhaime A.C., Sutton L., Phillips P.C. Role of MAP kinase pathways in primitive neuroectodermal tumors. Anticancer Res. 21:2001;2733-2738
27. Dannenberg J.H., van Rossum A., Schuijff L., te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14:2000;3051-3064
28. Dent P., Yacoub A., Fisher P.B., Hagan M.P., Grant S. MAPK pathways in radiation responses. Oncogene. 22:2003;5885-5896
29. Diehl N.L., Enslen H., Fortner K.A., Merritt C., Stetson N., Charland C., Flayell R.A., Davis R.J., Rineon M. Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo. J. Exp. Med. 191:2000;321-334
30. Dmitrieva N.I., Bulavin D.V., Fornace A.J.J., Burg M.B. Rapid activation of G2M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase. Proc. Natl. Acad. Sci. USA. 99:2002;184-189
31. Elenitoba-Johnson K.S., Jenson S.D., Abbott R.T., Palais R.A., Bohling S.D., Lin Z., Tripp S., Shami P.J., Wang L.Y., Coupland R.W., Buekstein R., Perez-Ordonez B., Perkins S.L., Dube I.D., Lim M.S. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc. Natl. Acad. Sci. USA. 100:2003;7259-7264
32. Ferbeyre G., de S.E., Querido E., Baptiste N., Prives C., Lowe S.W. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14:2000;2015-2027
33. Galaktionov K., Lee A.K., Eckstein J., Draetta G., Meckler J., Loda M. CDC25 phosphatases as potential human oncogenes. Science. 269:1995;1575-1577
34. Gallo K.A., Johnson G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3:2002;663-672
35. Garner A.P., Weston C.R., Todd D.E., Balmanno K., Cook S.J. Delta MEKK3:ER* activation induces a p38 alphabeta 2-dependent cell cycle arrest at the G2 checkpoint. Oncogene. 21:2002;8089-8104
36. Ghatan S., Larner S., Kinoshita Y., Hetman M., Patel L., Xia Z., Youle R.J., Morrison R.S. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150:2000;335-347
37. Gil J., Bernard D., Martinez D., Beach D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6:2004;67-72
38. Goldsmith E.J., Cobb M.H., Chang C.I. Structure of MAPKs. Methods Mol. Biol. 250:2004;127-144
39. Goloudina A., Yamaguchi H., Chervyakova D.B., Appella E., Fornace A.J.J., Bulavin D.V. Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint. Cell Cycle. 2:2003;473-478
40. Greenberg A.K., Basu S., Hu J., Yie T.A., Tchou-Wong K.M., Rom W.N., Lee T.C. Selective p38 activation in human non-small cell lung cancer. Am. J. Respir. Cell. Mol. Biol. 26:2002;558-564
41. Haq R., Brenton J.D., Takahashi M., Finan D., Finkielsztein A., Damaraju S., Rottapel R., Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 62:2002;5076-5082
42. Higashimoto Y., Saito S., Tong X.H., Hong A., Sakaguchi K., Appella E., Anderson C.W. Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J. Biol. Chem. 275:2000;23199-23203
43. Hirasawa A., Saito-Ohara F., Inoue J., Aoki D., Susumu N., Yokoyama T., Nozawa S., Inazawa J., Imoto I. Association of 17q21-q24 Gain in Ovarian Clear Cell Adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin. Cancer Res. 9:2003;1995-2004
44. Hommes D., van den Blink B., Plasse T., Bartelsman J., Xu C., Macpherson B., Tytgat G., Peppelenbosch M., Van Deventer S. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology. 122:2002;7-14
45. Huot T.J., Rowe J., Harland M., Drayton S., Brookes S., Gooptu C., Purkis P., Fried M., Bataille V., Hara E., Newton-Bishop J., Peters G. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol. Cell. Biol. 22:2002;8135-8143
46. Ishikawa Y., Kusaka E., Enokido Y., Ikeuchi T., Hatanaka H. Regulation of Bax translocation through phosphorylation at Ser-70 of Bcl-2 by MAP kinase in NO-induced neuronal apoptosis. Mol. Cell Neurosci. 24:2003;451-459
47. Iwasa H., Han J., Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells. 8:2003;131-144
48. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:1999;164-168
49. Jin S., Mazzacurati L., Zhu X., Tong T., Song Y., Shujuan S., Petrik K.L., Rajasekaran B., Wu M., Zhan Q. Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene. 22:2003;8536-8540
50. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:2002;1911-1912
51. Johnson G.V., Bailey C.D. The p38 MAP kinase signaling pathway in Alzheimer's disease. Exp. Neurol. 183:2003;263-268
52. Katayama M., Stokoe D., Haas-Kogan D.A., Berger M.S., Pieper R.O. The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol. Cell. Biol. 23:2003;8306-8315
53. Kato T.J., Delhase M., Hoffmann A., Karin M. CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol. Cell. 12:2003;829-839
54. Keller D.M., Zeng X., Wang Y., Zhang Q.H., Kapoor M., Shu H., Goodman R., Lozano G., Zhao Y., Lu H. A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol. Cell. 7:2001;283-292
55. Kishi H., Nakagawa K., Matsumoto M., Suga M., Ando M., Taya Y., Yamaizumi M. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J. Biol. Chem. 276:2001;39115-39122
56. Kovalsky O., Lung F.D., Roller P.P., Fornace A.J.J. Oligomerization of human gadd45a protein. J. Biol. Chem. 276:2001;39330-39339
57. Kumar S., Boehm J., Lee J.C. p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2:2003;717-726
58. Kyriakis J.M., Liu H., Chadee D.N. Activation of SAPKsJNKs and p38s in vitro. Methods Mol. Biol. 250:2004;61-88
59. Landesman-Bollag E., Romieu-Mourez R., Song D.H., Sonenshein G.E., Cardiff R.D., Seldin D.C. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene. 20:2001;3247-3257
60. Lavoie J.N., L'Allemain G., Brunet A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42p44MAPK and negatively by the p38HOGMAPK pathway. J. Biol. Chem. 271:1996;20608-20616
61. Lee S.J., Drabik K., Van Wagoner N.J., Lee S., Choi C., Dong Y., Benveniste E.N. ICAM-1-induced expression of proinflammatory cytokines in astrocytes: Involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J. Immunol. 165:2000;4658-4666
62. Liao Y., Hung M.C. Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis. Mol. Cell. Biol. 23:2003;6836-6848
63. Liu Z.G., Baskaran R., Lea-Chou E.T., Wood L.D., Chen Y., Karin M., Wang J.Y. Three distinct signalling responses by murine fibroblasts to genotoxic. Nature. 384:1996;273-276
64. Lundberg A.S., Hahn W.C., Gupta P., Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:2000;705-709
65. Mailand N., Falck J., Lukas C., Syljuasen R.G., Welcker M., Bartek J., Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science. 288:2000;1425-1429
66. Margolis S.S., Walsh S., Weiser D.C., Yoshida M., Shenolikar S., Kornbluth S. PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J. 22:2003;5734-5745
67. Miki H., Yamada H., Mitamura K. Involvement of p38 MAP kinase in apoptotic and proliferative alteration in human colorectal cancers. Anticancer Res. 19:1999;5283-5291
68. Molinari M., Mercurio C., Dominguez J., Goubin F., Draetta G.F. Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 1:2000;71-79
69. Molnar A., Theodoras A.M., Zon L.I., Kyriakis J.M. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1S through a mechanism requiring p38RK. J. Biol. Chem. 272:1997;13229-13235
70. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 409:2001;1067-1070
71. Pargellis C., Regan J. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Curr. Opin. Investig. Drugs. 4:2003;566-571
72. Passegue E., Wagner E.F. JunB suppresses cell proliferation by transcriptional activation of p16 (INK4a) expression. EMBO J. 19:2000;2969-2979
73. Pearce A.K., Humphrey T.C. Integrating stress-response and cell-cycle checkpoint pathways. Trends Cell Biol. 11:2001;426-433
74. Peeper D.S., Dannenberg J.H., Douma S., te Riele H., Bernards R. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat. Cell Biol. 3:2001;198-203
75. Pruitt K., Pruitt W.M., Bilter G.K., Westwick J.K., Der C.J. Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation. J. Biol. Chem. 277:2002;31808-31817
76. Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000
77. Raoul C., Estevez A.G., Nishimune H., Cleveland D.W., deLapeyriere O., Henderson C.E., Haase G., Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron. 35:2002;1067-1083
78. Reynolds C.H., Betts J.C., Blackstock W.P., Nebreda A.R., Anderton B.H. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem. 74:2000;1587-1595
79. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 404:2000;892-897
80. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:2000;3037-3050
81. Saito S., Yamaguchi H., Higashimoto Y., Chao C., Xu Y., Fornace A.J.J., Appella E., Anderson C.W. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278:2003;37536-37544
82. Saito-Ohara F., Imoto I., Inoue J., Hosoi H., Nakagawara A., Sugimoto T., Inazawa J. PPMID is a potential target for 17q gain in neuroblastoma. Cancer Res. 63:2003;1876-1883
83. Sampson E.M., Haque Z.K., Ku M.C., Tevosian S.G., Albanese C., Pestell R.G., Paulson K.E., Yee A.S. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J. 20:2001;4500-4511
84. Sanchez-Prieto R., Rojas J.M., Taya Y., Gutkind J.S. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60:2000;2464-2472
85. Sanchez-Prieto R., Sanchez-Arevalo V.J., Servitja J.M., Gutkind J.S. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene. 21:2002;974-979
86. Sayed M., Kim S.O., Salh B.S., Issinger O.G., Pelech S.L. Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase. J. Biol. Chem. 275:2000;16569-16573
87. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602
88. Shay J.W., Pereira-Smith O.M., Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell. Res. 196:1991;33-39
89. Shi Y., Gaestel M. In the cellular garden of forking paths: How p38 MAPKs signal for downstream assistance. Biol. Chem. 383:2002;1519-1536
90. Takekawa M., Adachi M., Nakahata A., Nakayama I., Itoh F., Tsukuda H., Taya Y., Imai K. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19:2000;6517-6526
91. Takekawa M., Saito H. A family of stress-inducible GADD45-like proteins mediate activation. Cell. 95:1998;521-530
92. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M. Requirement for p38alpha in erythropoietin expression: A role for stress kinases in erythropoiesis. Cell. 102:2000;221-231
93. Tarn C., Zou L., Hullinger R.L., Andrisani O.M. Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. J. Virol. 76:2002;9763-9772
94. Tevosian S.G., Shih H.H., Mendelson K.G., Sheppard K.A., Paulson K.E., Yee A.S. HBP1: A HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 11:1997;383-396
95. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310
96. Voorhoeve P.M., Agami R. The tumor-suppressive functions of the human INK4A locus. Cancer Cell. 4:2003;311-319
97. Vousden K.H., Lu X. Live or let die: The cell's response to p53. Nat. Rev. Cancer. 2:2002;594-604
98. Waetzig G.H., Seegert D., Rosenstiel P., Nikolaus S., Schreiber S. p38 mitogen-activated protein kinase is activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J. Immunol. 168:2002;5342-5351
99. Wang Q., Ding Q., Dong Z., Ehlers R.A., Evers B.M. Downregulation of mitogen-activated protein kinases in human colon cancers. Anticancer Res. 20:2000;75-83
100. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK36-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 22:2002;3389-3403
101. Wang X., McGowan C.H., Zhao M., He L., Downey J.S., Fearns C., Wang Y., Huang S., Han J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20:2000;4543-4552
102. Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., Lucius R. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: Implications for Parkinson's disease. FASEB J. 17:2003;500-502
103. Wu H., Lozano G. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269:1994;20067-20074
104. Wulf G.M., Liou Y.C., Ryo A., Lee S.W., Lu K.P. Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and cell cycle checkpoints in response to dna damage. J. Biol. Chem. 277:2002;47976-47979
105. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20:2001;3459-3472
106. Xiu M., Kim J., Sampson E., Huang C.Y., Davis R.J., Paulson K.E., Yee A.S. The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol. Cell. Biol. 23:2003;8890-8901
107. Yu Q., Geng Y., Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 411:2001;1017-1021
108. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., Ronai Z., Blandino G., Schneider C., Del S.G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature. 419:2002;853-857
109. Zhao H., Watkins J.L., Piwnica-Worms H. Disruption of the checkpoint kinase 1cell division cycle 25 A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. USA. 99:2002;14795-14800
110. Zheng H., You H., Zhou X.Z., Murray S.A., Uchida T., Wulf G., Gu L., Tang X., Lu K.P., Xiao Z.X. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature. 419:2002;849-853
111. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:1998;2997-3007